isoxazoles has been researched along with gw 7647 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dullens, SP; Mariman, EC; Mensink, RP; Plat, J | 1 |
Baruchet, M; Casals-Casas, C; Desvergne, B; Naldi, A; Pradervand, S; Trang, KB; Wigger, L | 1 |
2 other study(ies) available for isoxazoles and gw 7647
Article | Year |
---|---|
Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; Butyrates; Caco-2 Cells; Cell Differentiation; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Intestine, Small; Isoxazoles; Models, Biological; Peroxisome Proliferators; Phenylurea Compounds; Pyrimidines; Receptors, Cytoplasmic and Nuclear | 2009 |
System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells.
Topics: Benzoates; Benzylamines; Butyrates; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Line; Cell Proliferation; Gene Expression; Gene Expression Regulation; Hepatocytes; Humans; Isoxazoles; Liver; Liver X Receptors; Orphan Nuclear Receptors; Phenylurea Compounds; PPAR alpha; Promoter Regions, Genetic; Receptor Cross-Talk; Receptors, Cytoplasmic and Nuclear; Systems Analysis | 2019 |